Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
701-301: A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (Gilt-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects with Late-onset Pompe disease.
Charrow, Joel
(PD/PI)
Burton, Barbara K
(Co-Investigator)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
9/2/14
→
2/25/17
Funding
BioMarin Pharmaceutical Inc.
View all
View less